Students involved in CHOC’s Research Institute were on winning teams with projects utilizing AI to improve patient outcomes.
The most common type of dwarfism, achondroplasia can now be treated with Voxzogo starting at birth, maximizing children’s growth potential.
The center becomes the first in the country to administer a commercial gene therapy infusion to treat Hemophilia A, the common disorder affecting males.
CHOC “lets the data speak for itself” in first-of-its-kind study into pediatric injuries sustained during law enforcement encounters.
CHOC aims to improve care of neonatal seizures through research into medications with fewer side effects than traditional anti-epileptics.
CHOC uses innovative artificial intelligence (AI) tools to restore sagittal alignment using patient-specific rods to treat scoliosis.